These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 18178151

  • 41. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
    Wang Y, Xu M, Che M, Von Hofe E, Abbas A, Kallinteris NL, Lu X, Liss ZJ, Forman JD, Hillman GG.
    Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
    [Abstract] [Full Text] [Related]

  • 42. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
    Martins I, Deshayes F, Baton F, Forget A, Ciechomska I, Sylla K, Aoudjit F, Charron D, Al-Daccak R, Alcaide-Loridan C.
    Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
    [Abstract] [Full Text] [Related]

  • 43. Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells.
    Fan P, Wang S, Liu X, Zhen L, Wu Z.
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):327-30. PubMed ID: 12408756
    [Abstract] [Full Text] [Related]

  • 44. The context of HLA-DR/CD18 complex in the plasma membrane governs HLA-DR-derived signals in activated monocytes.
    Doisne JM, Castaigne JG, Deruyffelaere C, Dieu-Nosjean MC, Chamot C, Alcaide-Loridan C, Charron D, Al-Daccak R.
    Mol Immunol; 2008 Feb; 45(3):709-18. PubMed ID: 17719638
    [Abstract] [Full Text] [Related]

  • 45. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
    Berghuis D, de Hooge AS, Santos SJ, Horst D, Wiertz EJ, van Eggermond MC, van den Elsen PJ, Taminiau AH, Ottaviano L, Schaefer KL, Dirksen U, Hooijberg E, Mulder A, Melief CJ, Egeler RM, Schilham MW, Jordanova ES, Hogendoorn PC, Lankester AC.
    J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
    [Abstract] [Full Text] [Related]

  • 46. MHC Class II levels and intracellular localization in human dendritic cells are regulated by calmodulin kinase II.
    Herrmann TL, Agrawal RS, Connolly SF, McCaffrey RL, Schlomann J, Kusner DJ.
    J Leukoc Biol; 2007 Sep; 82(3):686-99. PubMed ID: 17586661
    [Abstract] [Full Text] [Related]

  • 47. Tofacitinib enhances interferon-γ-induced expression of major histocompatibility complex class II in macrophages.
    Mizuno N, Yanagawa Y.
    Eur J Pharmacol; 2022 Jan 15; 915():174564. PubMed ID: 34919889
    [Abstract] [Full Text] [Related]

  • 48. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism].
    Ou QS, Lin L, Huang LD, Lu PH, Zhou GY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep 15; 19(5):417-20. PubMed ID: 15169643
    [Abstract] [Full Text] [Related]

  • 49. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
    Ouyang GF, Saio M, Suwa T, Imai H, Nakagawa J, Nonaka K, Umemura N, Kijima M, Takami T.
    Int J Oncol; 2006 May 15; 28(5):1201-8. PubMed ID: 16596236
    [Abstract] [Full Text] [Related]

  • 50. Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis.
    Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean MC, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al-Daccak R.
    Melanoma Res; 2009 Aug 15; 19(4):226-37. PubMed ID: 19574933
    [Abstract] [Full Text] [Related]

  • 51. Expression of major histocompatibility complex class II and costimulatory molecules in oral carcinomas in vitro.
    Villarroel-Dorrego M, Speight PM, Barrett AW.
    Med Oral Patol Oral Cir Bucal; 2005 Aug 15; 10(3):188-95. PubMed ID: 15876961
    [Abstract] [Full Text] [Related]

  • 52. Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas.
    Anderson RC, Anderson DE, Elder JB, Brown MD, Mandigo CE, Parsa AT, Goodman RR, McKhann GM, Sisti MB, Bruce JN.
    Neurosurgery; 2007 Jun 15; 60(6):1129-36; discussion 1136. PubMed ID: 17538388
    [Abstract] [Full Text] [Related]

  • 53. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
    van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, van den Elsen PJ.
    Mol Immunol; 2007 Mar 15; 44(8):2036-46. PubMed ID: 17067677
    [Abstract] [Full Text] [Related]

  • 54. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR, Zhang H, Blanck G.
    Mol Immunol; 2006 Feb 15; 43(6):710-6. PubMed ID: 16360016
    [Abstract] [Full Text] [Related]

  • 55. Pancreatic islets activate portal vein endothelial cells in vitro.
    Fontaine MJ, Blanchard J, Rastellini C, Lazda V, Herold KC, Pollak R.
    Ann Clin Lab Sci; 2002 Feb 15; 32(4):352-61. PubMed ID: 12458886
    [Abstract] [Full Text] [Related]

  • 56. Expression of major histocompatibility complex class I and class II antigens in canine masticatory muscle myositis.
    Paciello O, Shelton GD, Papparella S.
    Neuromuscul Disord; 2007 Apr 15; 17(4):313-20. PubMed ID: 17360184
    [Abstract] [Full Text] [Related]

  • 57. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
    Powis SJ.
    FEBS Lett; 2006 May 29; 580(13):3112-6. PubMed ID: 16678175
    [Abstract] [Full Text] [Related]

  • 58. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1.
    Sakaguchi H, Miyazawa M, Yoshida Y, Ito Y, Suzuki H.
    Arch Dermatol Res; 2007 Feb 29; 298(9):427-37. PubMed ID: 17119987
    [Abstract] [Full Text] [Related]

  • 59. Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes.
    Speth C, Bredl S, Hagleitner M, Wild J, Dierich M, Wolf H, Schroeder J, Wagner R, Deml L.
    Virology; 2008 Dec 05; 382(1):46-58. PubMed ID: 18945465
    [Abstract] [Full Text] [Related]

  • 60. Expression of surface markers on the human monocytic leukaemia cell line, THP-1, as indicators for the sensitizing potential of chemicals.
    An S, Kim S, Huh Y, Lee TR, Kim HK, Park KL, Eun HC.
    Contact Dermatitis; 2009 Apr 05; 60(4):185-92. PubMed ID: 19338585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.